5.71BMarket Cap32.95P/E (TTM)
8.575High8.270Low605.89KVolume8.280Open9.220Pre Close5.11MTurnover0.11%Turnover Ratio88.43P/E (Static)679.63MShares12.15052wk High1.01P/B4.60BFloat Cap5.30052wk Low--Dividend TTM547.94MShs Float24.895Historical High--Div YieldTTM3.31%Amplitude3.642Historical Low8.431Avg Price1Lot Size
Grifols Stock Forum
Benzinga· 3 mins ago
FDA Approves Expanded Label For Grifols' XEMBIFY, The First 20% SCIg For Treatment-Naïve Patients With Primary Humoral Immunodeficiencies; Approval Includes Biweekly Dosing Following Positive Phase 4 Data, Enhancing Flexibility And Convenience For Patients
Welcome to the end of the dog days of summer for a while; my name is Kevin Travers, and here are stories from the moomoo herd on Wall Street today.
$Intel (INTC.US)$ traded higher after the firm said it had bypassed Vietnam for a $3.3B project and in...
2. $Inspire Veterinary Partners (IVP.US)$
3. $Dynatronics (DYNT.US)$
4. $Zapp Electric Vehicles (ZAPP.US)$
5. $Maxeon Solar Technologies (MAXN.US)$
6. $Grifols (GRFS.US)$
7. $SinglePoint (SING.US)$
8. $Venus Concept (VERO.US)$
9. $IDEAYA Biosciences (IDYA.US)$
10. $Kuke Music (KUKE.US)$
- Reuters
Benzinga· 1 min ago
No comment yet